Novo A/S »

Maplight Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2025-12-31 $65M 3.7M 17.57

More positions owned by Novo A/S

Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Asml Holding N V N Y Registry Shs (ASML)
Mirum Pharmaceuticals (MIRM)
salesforce (CRM)
Crinetics Pharmaceuticals In (CRNX)
Miragen Therapeutics (VRDN)
Maplight Therapeutics (MPLT)
Zenas Biopharma (ZBIO)
Pharvaris N V (PHVS)
Apogee Therapeutics (APGE)
Vaxcyte (PCVX)
BioMarin Pharmaceutical (BMRN)
Arrivent Biopharma (AVBP)
Alibaba Group Hldg Sponsored Ads (BABA)

View all positions for Novo A/S

Top funds holding Maplight Therapeutics

Novo A/S
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners
Polygon Management
Bnp Paribas Investment Partners

View all funds holding Maplight Therapeutics